If Monistat didn’t clear your symptoms, you’re not alone. FDA clinical trial data show that miconazole (the active ingredient in Monistat) has a therapeutic cure rate of only 58% to 67% about a month after treatment. That means roughly one in three women who use it don’t get better. The reasons range from a wrong initial diagnosis to a resistant yeast strain, and figuring out which applies to you determines what to do next.
It Might Not Be a Yeast Infection
The most common reason Monistat fails is that the problem was never a yeast infection in the first place. Several conditions cause nearly identical symptoms, and studies show that self-diagnosis is wrong about half the time. A medical history alone isn’t enough for an accurate diagnosis, which is why lab testing matters.
Bacterial vaginosis (BV) is the most frequent look-alike. It can cause itching and increased discharge, but the discharge tends to be grayish and foamy with a fishy odor, rather than the thick, white, odorless discharge typical of yeast. BV sometimes has no noticeable symptoms at all, which makes it easy to confuse with a mild yeast infection. Monistat does nothing for BV because it’s caused by bacteria, not yeast.
Trichomoniasis, a sexually transmitted infection caused by a parasite, is another possibility. Its discharge is often frothy, yellow-green, and foul-smelling, sometimes with spots of blood. Again, antifungals won’t touch it.
A lesser-known condition called cytolytic vaginosis mimics yeast infections so closely that researchers believe many cases labeled “treatment-resistant yeast” are actually this condition. It causes white discharge, itching, painful sex, and vulvar irritation. The cause is an overgrowth of lactobacilli (the “good” bacteria), which makes the vagina too acidic and damages the vaginal lining. Antifungals don’t help, and treatment actually involves raising vaginal pH, the opposite approach of treating yeast.
Your Yeast Strain May Be Resistant
If you do have a confirmed yeast infection, the species of yeast matters. Most vaginal yeast infections are caused by Candida albicans, and most of those respond to Monistat. But in FDA trials, 10% to 15% of C. albicans strains didn’t respond to miconazole treatment. Azole resistance in C. albicans is becoming more common over time.
Non-albicans species are a bigger problem. Candida glabrata, the second most common species, is intrinsically resistant to azole antifungals, the entire drug class that includes Monistat. In clinical trials, miconazole cured only 14% to 20% of C. glabrata infections. If you’ve used Monistat and your symptoms haven’t budged, a resistant strain is a real possibility, especially if you’ve had multiple yeast infections treated with over-the-counter products in the past.
When to Decide It’s Not Working
The Monistat label is specific: if your symptoms haven’t improved within 3 days, stop using the product and see a healthcare provider. Some mild irritation during treatment is normal, but worsening itching, burning, or no change at all after 3 days signals that something else is going on. Don’t repeat a second course of Monistat hoping for different results. If the first round failed, a second is unlikely to succeed, and you’ll just delay getting the right treatment.
What a Doctor Can Actually Test For
A proper evaluation goes well beyond a visual exam. In the office, a provider can check vaginal pH with test paper, examine discharge under a microscope, and use a potassium hydroxide (KOH) preparation to look for yeast structures. But microscopy only catches about 50% of yeast infections, so a negative slide doesn’t rule one out. If microscopy is inconclusive, a yeast culture is the next step. Cultures can identify the exact species of Candida and, in some labs, test which antifungals it’s susceptible to.
You can buy home vaginal pH test kits, but the FDA notes that pH changes don’t reliably distinguish one type of infection from another, and a normal pH doesn’t confirm yeast. These kits can offer a clue (yeast infections typically don’t raise pH, while BV does), but they aren’t a substitute for a clinical workup.
Treatment Options Beyond Monistat
Once a provider confirms yeast and identifies the species, treatment gets more targeted. For standard C. albicans infections that didn’t respond to over-the-counter miconazole, a prescription oral antifungal is the typical next step. This is more convenient than topical creams and reaches tissue that topical products sometimes miss.
For non-albicans species like C. glabrata, the approach is different. A longer course of a non-fluconazole antifungal, typically 7 to 14 days, is recommended. If that doesn’t work, boric acid vaginal suppositories (600 mg daily for 3 weeks) are the standard alternative. Boric acid achieves cure rates of about 70% for resistant strains. It’s available over the counter but should be used under a provider’s guidance, not as a first-line experiment.
If Yeast Infections Keep Coming Back
Recurrent vulvovaginal candidiasis, defined as four or more infections in a year, requires a different strategy than treating each episode individually. The CDC recommends starting with a longer initial treatment course of 7 to 14 days to fully clear the yeast, followed by a maintenance regimen of a weekly oral antifungal for six months. This suppressive approach keeps yeast levels low enough to prevent flare-ups.
If symptoms persist even on maintenance therapy, culture and susceptibility testing become essential. Resistance patterns can shift over time, especially with repeated antifungal use, so what worked a year ago may no longer be effective. Providers with expertise in recurrent infections can adjust treatment based on those results. Women who cycle through over-the-counter products without lab confirmation often end up in a frustrating loop of partial improvement and relapse that a targeted approach can break.